April 7 (Reuters) - Scope Fluidics SA SCPP.WA :
* UNIT CURIOSITY DIAGNOSTICS COMPLETES FIFTH STAGE OF
RESEARCH AND
DEVELOPMENT WORKS ON PCR|ONE SYSTEM
* RESULTS CONFIRM HIGH CLINICAL EFFECTIVENESS OF PCR|ONE
SYSTEM,
WITH MARKER PARAMETERS IN LINE WITH MARKET STANDARDS
* SAYS CO DECIDES TO EXPAND WORKS ON PANEL FOR DETECTING
VIRAL
RESPIRATORY INFECTION
* SAYS EXPANSION TO INCLUDE DEVELOPMENT OF ULTRAFAST GENETIC
SARS-COV-2 RECOGNITION TEST
Source text for Eikon: ID:nEM2S2L9Wa
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))